Updated August 2, 2026

CVS Caremark Prior Authorization 2026: By Drug, Form & Status Check

Evan Brown
Written by Evan Brown
Prescription Savings Researcher
Dr Megan Harris Medically Reviewed by Dr. Megan Harris, MD
Editorial Review: This guide explains how CVS Caremark, one of the largest pharmacy benefit managers (PBMs) in the United States, processes prior authorization requests, including submission channels, timelines, common denial reasons, and the appeals process.
Quick Answer

CVS Caremark is a pharmacy benefit manager (PBM), not an insurance company itself. It processes prior authorization requests on behalf of the employer plans, health insurers, and government programs that hire it to manage prescription benefits. Prescribers typically submit requests through CoverMyMeds or another ePA platform, by fax using a plan-specific form, or by phone. Electronic requests are usually decided within 24 to 72 hours, while fax or manual reviews can take up to two weeks. Because Caremark administers thousands of different plan designs, the specific clinical criteria and forms depend on the plan sponsor, not on Caremark's name alone. If a request is denied, both the prescriber and the member have appeal rights, and urgent cases can request an expedited review.

🆕 2026 Federal Rule Change (CMS-0057-F):

Starting January 1, 2026, CVS Caremark and all Medicare/Medicaid payers must respond to prior authorization requests faster:

  • Standard requests: Decision within 7 calendar days (down from 14 days)
  • Expedited/urgent requests: Decision within 72 hours
  • Electronic submissions: Many decisions now returned in under 4 minutes via automated ePA platforms
  • Denial transparency: Payers must now provide specific, actionable denial reasons (not generic rejections)

If your request exceeds these timelines, you have grounds to escalate. See the escalation section below.

Need to check your PA status or submit urgently?

Call the correct CVS Caremark line for your plan type:

Commercial / Employer Plans

1-800-294-5979

Medicare Part D

1-855-344-0930

Medicaid

1-877-433-7643

Non-Medicare Fax

1-888-836-0730

Check Status Online →

Hours: Monday–Friday, 8am–6pm CST. Prescribers can also use CoverMyMeds or Surescripts for electronic submission.

Key Takeaways

  • CVS Caremark is a PBM that administers pharmacy benefits for employers, insurers, and government plans — it is not itself the insurance company.
  • Electronic prior authorization (ePA) through CoverMyMeds is the fastest submission method.
  • Turnaround time ranges from 24 hours (electronic, urgent) to 7 calendar days (standard fax or paper submissions).
  • Clinical criteria and forms vary by the specific plan Caremark is administering, not by Caremark corporately.
  • Denials can be appealed, and specialty medications often route through CVS Specialty Pharmacy for both fulfillment and clinical review.

Common Drugs Requiring CVS Caremark Prior Authorization

Prior authorization requirements vary significantly by medication class. Here are the most commonly searched drugs under Caremark-administered plans in 2026:

Drug Type Typical PA Trigger Routes Through
Ozempic (semaglutide) GLP-1 injectable Type 2 diabetes diagnosis, A1C, step therapy Retail or CVS Specialty
Wegovy (semaglutide) GLP-1 injectable BMI documentation, weight-related comorbidities CVS Specialty
Mounjaro (tirzepatide) GLP-1/GIP Type 2 diabetes diagnosis, metformin trial Retail or CVS Specialty
Cosentyx (secukinumab) Biologic (IL-17) Step therapy, specialty pharmacy CVS Specialty
Skyrizi (risankizumab) Biologic (IL-23) Step therapy, specialist prescriber CVS Specialty
Humira (adalimumab) Biologic (TNF-alpha) Biosimilar preference, step therapy CVS Specialty
Stelara (ustekinumab) Biologic (IL-12/23) Step therapy, TB screening CVS Specialty

Note: Caremark-administered plans increasingly require biologics and specialty medications to route through CVS Specialty Pharmacy rather than retail locations. If your PA was denied for "incorrect pharmacy type," ask your prescriber to resend the prescription to CVS Specialty.

If your pharmacist tells you a prescription needs prior authorization and your insurance card lists CVS Caremark as the pharmacy benefit manager, it helps to understand who actually makes the coverage decision. Caremark doesn't set its own universal medical policy the way a health insurer does — it administers pharmacy benefits on behalf of thousands of different employer groups, health plans, and government programs, each with its own formulary and clinical criteria.

That distinction matters because two people with a CVS Caremark ID card can have completely different prior authorization requirements, simply because their employer or health plan chose different coverage rules. What stays consistent across nearly every Caremark-administered plan is the process: how a request gets submitted, how long it typically takes, and what happens if it's denied.

This guide walks through that process step by step, so you and your prescriber know exactly what to expect and how to avoid the most common causes of delay.

Table of Contents

  1. What CVS Caremark Actually Does
  2. How to Submit a Prior Authorization
  3. Cosentyx Prior Authorization Requirements
  4. Common Drugs Requiring PA
  5. Caremark Prior Authorization Turnaround Times
  6. Required Documentation
  7. How Specialty Medications Are Handled
  8. How to Check Your Status
  9. Common Reasons for Denial
  10. How to Appeal a Denial
  11. Expedited & Urgent Reviews
  12. What to Do If Your Plan Isn't Cooperating
  13. Frequently Asked Questions

What CVS Caremark Actually Does

CVS Caremark is a pharmacy benefit manager. It contracts with employers, health insurance companies, and government programs to manage the prescription drug portion of a health plan. That includes building formularies, negotiating drug pricing, processing pharmacy claims, and administering prior authorization on behalf of the plan sponsor.

Role Who Sets the Rules What Caremark Does
Formulary Design Plan sponsor (employer/insurer), often with Caremark's input Builds and maintains the covered drug list
Clinical Criteria Plan sponsor, sometimes using Caremark's standard templates Applies criteria during clinical review
Prior Authorization Review Caremark clinical staff, per the plan's approved criteria Processes and decides the request
Appeals Plan sponsor's appeal policy Administers the appeal process

Why this matters: If two coworkers at the same company both have Caremark on their insurance card, they likely share the same formulary and criteria. But if you and a friend both have "Caremark" printed on your card through two different employers, your actual coverage rules can be completely different.

How to Submit a Prior Authorization to Caremark

Most Caremark prior authorization requests are initiated by the prescriber's office, not the patient directly. There are three common submission channels.

Method Who Uses It Typical Speed
Electronic Prior Authorization (ePA) Most prescriber offices, via CoverMyMeds or Surescripts Fastest
Fax Submission Offices without ePA integration Moderate
Phone Request Urgent cases or when forms are unavailable Varies

CVS Caremark Prior Authorization Form

There is no single universal Caremark PA form. Each employer and health plan that uses Caremark has its own plan-specific prior authorization form, which the pharmacy system generates when a claim is rejected. Here's how to get the right one:

  • For prescribers: The correct form auto-populates in CoverMyMeds or your EHR's ePA module when you select the patient's plan.
  • For patients: Ask your pharmacist for the fax number and form code printed on the rejection message — this ensures your prescriber's office submits to the correct review queue.
  • By phone: Call the Caremark prior authorization line at 1-800-294-5979 and reference your plan's BIN/PCN numbers to request the correct form be faxed to your provider.

Common mistake: Using a generic "CVS Caremark prior authorization form" downloaded from a third-party site. These are often outdated or for a different plan sponsor, which causes an automatic rejection or delay.

Step-by-Step: Submitting an Electronic Prior Authorization

1

Pharmacy flags the need for PA

When a claim is rejected at the pharmacy counter, the system generates a rejection code indicating prior authorization is required, along with the plan-specific fax number or ePA routing information.

2

Prescriber's office opens the ePA request

The office logs into CoverMyMeds (or an integrated EHR ePA module) and selects the correct plan, which pulls up the specific clinical questionnaire tied to your formulary.

3

Clinical questionnaire is completed

The provider answers plan-specific clinical questions covering diagnosis, prior treatments, lab values, and medical necessity, based on your chart.

4

Request is submitted electronically

The completed form routes directly to Caremark's clinical review team, avoiding fax delays and lost paperwork.

5

Decision is returned

Caremark issues an approval, a request for additional information, or a denial, typically visible in the ePA portal within one to three business days.

Electronic Prior Authorization Platforms (2026)

While CoverMyMeds handles roughly 90% of U.S. ePA volume and remains the default for most CVS Caremark plans, Surescripts has emerged as a major alternative in 2025–2026.

CoverMyMeds vs Surescripts: CoverMyMeds is the default for most Caremark-administered plans. However, CVS Caremark is actively expanding use of Surescripts Touchless Prior Authorization — an automated system that retrieves clinical data directly from your EHR and sends it to the PBM without manual form-filling. In pilot programs, Touchless PA delivered approvals in under 30 seconds and reduced appeals caused by missing clinical information by 88%. If your prescriber's EHR supports Surescripts, ask whether your plan routes through CoverMyMeds or Surescripts before submitting.

Bottom line: Both platforms are free for prescribers. CoverMyMeds has broader plan coverage; Surescripts offers faster automated approvals for eligible medications. Your doctor's office likely knows which system your specific Caremark plan uses.

CVS Caremark Prior Authorization for Cosentyx (Secukinumab)

Cosentyx is a biologic injectable used for plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Because it is a specialty medication administered through CVS Specialty Pharmacy, the prior authorization process involves additional clinical documentation beyond standard retail drugs.

Cosentyx PA requirements for CVS Caremark (2026)
Required Documentation Why Caremark Asks for It
Confirmed diagnosis (ICD-10: L40.9 for psoriasis, M07.6 for psoriatic arthritis, M45.9 for AS) Verifies FDA-approved indication matches prescription
Prescriber specialty — Dermatology or Rheumatology Biologics typically require specialist prescribing
Prior therapy failure — Topicals, phototherapy, or conventional DMARDs Caremark requires step therapy documentation before approving biologics
TB test results (negative within 6 months) Standard safety requirement for all TNF-alpha and IL-17 inhibitors
Hepatitis B/C screening Required for immunosuppressive biologic therapy
Baseline labs (CBC, liver function) Monitoring requirement for specialty pharmacy dispensing

How your doctor submits: Because Cosentyx routes through CVS Specialty Pharmacy, your prescriber should initiate the PA through CoverMyMeds or fax the plan-specific form directly to CVS Specialty at 1-800-237-2767. The prescription should be sent to CVS Specialty, not a retail pharmacy, or the PA will be rejected for incorrect routing.

Common Cosentyx PA denial: Caremark denies Cosentyx when the prescription is sent to a retail CVS instead of CVS Specialty, or when step therapy documentation (prior topical/oral failure) is missing. If denied, ask your dermatologist/rheumatologist to provide chart notes showing 3+ months of prior therapy without adequate response.

Caremark Prior Authorization Turnaround Times

Turnaround time depends heavily on submission method and whether the request is marked urgent. New for 2026: Federal CMS-0057-F rules now cap decision times.

CVS Caremark PA turnaround times (2026 — updated for CMS-0057-F)
Request Type Federal Max (CMS-0057-F) Typical Actual Speed
Standard Electronic (ePA) 7 calendar days 24–72 hours
Urgent / Expedited Electronic 72 hours As fast as 4 minutes (automated)
Fax Submission 7 calendar days 3–5 business days
Incomplete Submission (any method) Clock resets upon resubmission +3–7 days after fix
Appeal Review Plan-dependent 7–30 days

What changed in 2026: The CMS-0057-F rule shortened the federal maximum for standard PA decisions from 14 days to 7 calendar days. If Caremark exceeds this on a Medicare Advantage or Medicaid plan, you can file a complaint with CMS or your state insurance department. Expedited decisions must now come within 72 hours — many ePA requests are automated and return in minutes.

Required Documentation

While exact requirements vary by plan and drug, most Caremark-administered prior authorizations ask for the same categories of information.

Document Usually Requested
Diagnosis code(s) Yes
Relevant lab results Often
Prior medication trials and outcomes Often
Office visit / progress notes Sometimes
Letter of medical necessity For complex or appealed cases

How Specialty Medications Are Handled

Many high-cost specialty drugs dispensed under Caremark-administered plans route through CVS Specialty Pharmacy, which handles both the prior authorization coordination and the actual medication fulfillment.

Step What Happens
Referral to Specialty Prescriber sends the prescription directly to CVS Specialty Pharmacy
Benefits Investigation Specialty pharmacy checks coverage and prior authorization status
Clinical Coordination Specialty pharmacy staff may contact the prescriber for missing documentation
Delivery Scheduling Once approved, medication is scheduled for shipment or pickup

Specialty medications generally take longer to approve than standard retail prescriptions because they involve higher-touch clinical review and often carry stricter step therapy or lab-monitoring requirements.

Retail vs. Specialty Routing Error: The #1 reason biologic PA requests (Cosentyx, Skyrizi, Humira, Stelara) are denied is because the prescriber sent the prescription to a retail CVS pharmacy instead of CVS Specialty Pharmacy. Caremark administers retail benefits separately from specialty benefits. If your pharmacist says "this needs PA," verify whether the prescription was sent to the correct pharmacy type before resubmitting.

CVS Specialty Pharmacy: 1-800-237-2767 (enrollment & PA coordination)

How to Check Your CVS Caremark Prior Authorization Status (4 Ways)

Waiting without updates is the most frustrating part of the PA process. Here are four ways to check your status, ranked by speed:

Method Who Can Use It Speed What You Need
1. Ask your prescriber's office Anyone Fastest — real-time in CoverMyMeds/Surescripts portal Your name and prescription
2. Caremark Member Portal / App Members only Same day Member ID and login
3. Call the PA phone line Anyone 5–15 minutes hold time Member ID, drug name, prescriber name
4. Wait for mailed letter Anyone Slowest — 5–10 days after decision Nothing, but you'll be last to know

Pro tip: Don't wait for the mailed letter. Ask your prescriber's office to check their ePA portal first — they usually see the decision before you receive any notification. If it's been more than 7 calendar days (or 72 hours for urgent requests), call the PA line and reference the CMS-0057-F timeline.

Common Reasons Caremark Denies Requests

Most denials trace back to documentation or plan-design issues rather than the medication being categorically excluded.

Reason for Denial What It Means Possible Solution
Missing clinical documentation The request didn't answer required questions fully Resubmit with complete diagnosis, labs, and history
Step therapy not met Plan requires trying a preferred alternative first Document prior treatment failure or contraindication
Drug not on formulary The plan excludes this medication entirely Request a formulary exception or switch to a covered alternative
Quantity exceeds plan limit Requested amount is above the plan's dispensing limit Submit justification for the higher quantity or adjust the prescription
Off-label use Requested use isn't FDA-approved or plan-recognized Provide clinical literature supporting medical necessity, or appeal

Decision Tree: What Should You Do After a Denial?

Step 1: Does the denial letter cite missing documentation?

✔ Yes → Ask your prescriber's office to resubmit with the specific missing information.

✖ No → Continue to Step 2.


Step 2: Is the denial based on step therapy or formulary exclusion?

✔ Yes → Ask your prescriber to document why the preferred alternative isn't appropriate, or file a formulary exception request.

✖ No → Continue to Step 3.


Step 3: Do you disagree with the clinical basis for the denial?

✔ Yes → File a formal appeal with supporting clinical documentation.

✖ No → Discuss covered alternatives with your prescriber.

How to Appeal a Caremark Denial

Appeal rights and processes are ultimately governed by the plan sponsor, but Caremark administers the review on the plan's behalf.

1

Read the denial letter closely

It should state the specific reason for denial and instructions for filing an appeal, including deadlines.

2

Gather additional clinical evidence

Work with your prescriber to compile updated notes, lab results, prior treatment history, or a letter of medical necessity addressing the specific denial reason.

3

Submit the appeal within the deadline

Appeals are typically submitted by fax, mail, or through the Caremark provider portal, depending on the plan's process.

4

Track and follow up

Standard appeals are usually decided within 7 to 30 days. If your situation is urgent, ask specifically about expedited appeal options.

For a full breakdown of building a strong appeal packet, see our guide: How to Appeal a Prescription Denial.

Expedited & Urgent Reviews

If waiting for a standard decision could seriously jeopardize your health, prescribers can request an expedited review.

Situation Review Type Typical Timeframe
Non-urgent, stable condition Standard Review 24–72 hours (ePA) / up to 7 days (fax)
Health could be seriously jeopardized by delay Expedited Review As fast as 24 hours
Denied and appealing an urgent case Expedited Appeal Typically 72 hours or less

Your prescriber's office must mark the request as urgent and provide clinical justification — expedited status isn't automatic just because a patient feels the situation is time-sensitive.

What to Do If Your Plan Isn't Cooperating

Occasionally a request stalls for reasons that have nothing to do with clinical criteria — lost faxes, portal glitches, or unclear plan-specific rules. A few practical steps can help move things along.

  • Call the prior authorization phone number listed on your denial letter or the pharmacy's rejection message, and ask for a reference number for your request.
  • Confirm your prescriber's office is submitting to the correct plan-specific fax number or ePA routing, since generic Caremark numbers don't always route to the right review queue.
  • Ask your HR benefits contact (for employer plans) whether the plan has a designated escalation contact for stuck prior authorizations.
  • Request written confirmation of submission and expected decision date so you have a paper trail if follow-up is needed.

Caremark Prior Authorization by Plan Type

Caremark administers benefits across several very different plan categories, and the process can feel slightly different depending on which one applies to you.

Plan Type Who Sets Clinical Criteria Typical PA Volume
Self-Funded Employer Plan Employer, often using Caremark's standard templates Moderate to High
Fully Insured Commercial Plan Health insurer, administered by Caremark Moderate to High
Medicare Part D (Caremark-administered) CMS rules plus plan sponsor formulary High for specialty and GLP-1 drugs
Union / Taft-Hartley Plans Trust plan sponsor Varies widely

Key takeaway: If your employer switches insurance carriers but keeps CVS Caremark as the PBM, your formulary and prior authorization rules can still change completely, since the plan sponsor — not Caremark — sets the clinical policy.


Common Mistakes That Delay a Caremark Prior Authorization

  • □ Prescriber's office faxes a generic PA form instead of the plan-specific one.
  • □ ePA submitted under the wrong plan or BIN/PCN combination.
  • □ Diagnosis code doesn't match the medication's approved indication.
  • □ Lab results or prior therapy history left blank.
  • □ Quantity requested doesn't match the prescribing information.
  • □ Request marked routine when it should have been marked urgent.
  • □ Appeal submitted after the plan's filing deadline.
  • □ Follow-up call made without the request reference number on hand.

Most of these issues are administrative, not clinical — and most can be fixed with a single corrected resubmission rather than a full appeal.


Quick Checklist Before Your Provider Submits a Request

Checklist Item Status
Correct plan and BIN/PCN identified
Diagnosis code matches medication indication
Relevant lab values included
Prior therapy history documented
Requested quantity matches prescribing information
Urgent flag applied if clinically appropriate
Reference/confirmation number saved after submission

Sample Appeal Letter Following a Caremark Denial

When a request is denied, prescribers often submit a letter of medical necessity addressing the specific reason cited in the denial. The example below shows the general structure.


Date

CVS Caremark Prior Authorization Appeals

Re: Appeal for [Medication Name] Coverage

The patient has been under my care for [condition], confirmed by
[diagnosis code / relevant test results].

The initial request was denied for [specific reason listed on denial letter].
Based on the patient's clinical history, including [prior treatments and
outcomes], this medication is medically necessary to appropriately manage
the patient's condition.

Attached are:

• Office visit notes
• Relevant laboratory results
• Prior medication trial history
• Original denial notice

Thank you for your reconsideration of this request.

Appeals that directly address the specific denial reason, with supporting clinical evidence, are far more likely to succeed than appeals that simply restate the original request.


Bottom Line

CVS Caremark's prior authorization process is largely about verifying that a request matches the clinical criteria and formulary rules set by your specific employer or health plan. Electronic submission through CoverMyMeds is consistently the fastest and most reliable path, and most delays come down to incomplete documentation rather than an outright coverage exclusion.

If a request is denied, you have appeal rights, and urgent situations can qualify for expedited review. Working closely with your prescriber's office, and knowing which plan-specific form and fax number to use, is the most effective way to avoid unnecessary delays.


Frequently Asked Questions

No. CVS Caremark is a pharmacy benefit manager that administers the prescription drug portion of your health plan on behalf of your actual insurer, employer, or government program. The plan sponsor sets the clinical criteria; Caremark processes the request.

Prescribers typically submit requests electronically through CoverMyMeds or another ePA platform, by fax using the plan-specific prior authorization form, or by phone for urgent cases.

Your doctor should submit Cosentyx PA through CoverMyMeds or fax the plan-specific form to CVS Specialty Pharmacy (not retail Caremark). Required documentation includes:

  • Confirmed diagnosis by a dermatologist or rheumatologist
  • Documentation of prior topical, phototherapy, or conventional DMARD failure
  • Negative TB test within 6 months
  • Hepatitis B/C screening
  • Prescription routed to CVS Specialty Pharmacy, not retail

Electronic submissions are typically decided within 24–72 hours. Fax submissions take 3–5 business days. If denied, the most common reason is missing step therapy documentation or routing to a retail pharmacy instead of CVS Specialty.

Electronic requests are typically decided within 24 to 72 hours. Fax or manual submissions can take 3 to 14 business days, and incomplete submissions add further delay.

Members can check status through the Caremark member portal or app. Prescribers can check through the CoverMyMeds portal or by calling the prior authorization line listed on the fax cover sheet or denial letter.

You or your prescriber can file a formal appeal with additional clinical documentation. If the situation is urgent, an expedited appeal can typically be requested and decided within 72 hours or less.

No. Forms and clinical criteria are specific to the employer or health plan Caremark is administering. Using the wrong plan's form is a common cause of delay.

Pharmacists typically flag that a prior authorization is required and provide the routing information, but the prescriber's office generally completes and submits the clinical request.

Specialty medications routed through CVS Specialty Pharmacy often involve additional clinical coordination, benefits investigation, and monitoring requirements, which can extend the review timeline compared to standard retail prescriptions.

Yes, if delaying treatment could seriously jeopardize your health. Your prescriber's office needs to mark the request as urgent and provide clinical justification for the expedited timeline.

Your prescriber can request a formulary exception, providing clinical justification for why a covered alternative isn't appropriate. This is a separate process from a standard prior authorization, though it follows a similar documentation approach.

Generally, no. A new employer or plan means a new plan sponsor with potentially different clinical criteria, so a new prior authorization review is usually required even though Caremark still administers the benefit.

CVS Caremark uses different phone numbers depending on your plan type:

  • Commercial / Employer Plans: 1-800-294-5979
  • Medicare Part D: 1-855-344-0930
  • Medicaid: 1-877-433-7643

Calling the wrong number can result in being transferred multiple times. Always check your insurance card or pharmacy rejection message for the correct line.

Under the new CMS-0057-F rule effective January 1, 2026, Caremark must decide standard requests within 7 calendar days (down from 14) and expedited requests within 72 hours. In practice, electronic submissions through CoverMyMeds or Surescripts are often approved in 24–72 hours, and automated Surescripts Touchless PA can return decisions in under 30 seconds for qualifying medications.

Yes. The fastest way is to ask your prescriber's office to check their CoverMyMeds or Surescripts portal — they see real-time updates before you get any letter. Members can also check through the Caremark member portal or mobile app using their member ID.


How We Researched This Guide

This guide was prepared by the Refill Relay Editorial Team using publicly available pharmacy benefit manager process documentation, standard electronic prior authorization (ePA) industry practices, and general prior authorization and appeals timelines commonly used across PBM-administered health plans.

Every article undergoes editorial review for accuracy, readability, and consistency before publication. Our goal is to explain complex pharmacy benefit processes in clear language so patients and caregivers can navigate prior authorization with less friction.


References

  1. National Council for Prescription Drug Programs (NCPDP). Electronic Prior Authorization Standards.
  2. Centers for Medicare & Medicaid Services. Medicare Part D Prescription Drug Benefit Guidance.
  3. CoverMyMeds. Electronic Prior Authorization Provider Resources.
  4. America's Health Insurance Plans (AHIP). Prior Authorization Process Standards.

About Refill Relay

Refill Relay publishes evidence-based educational resources that help patients understand prescription insurance, prior authorization requirements, pharmacy benefits and medication access. Our editorial team combines process research with practical insurance guidance to make complex healthcare topics easier to navigate.

Editorial Standards

  • Evidence-based process research
  • Editorial review before publication
  • Regular updates when PBM processes change
  • Clear distinction between educational content and medical or legal advice

Prior Authorization by Medication

If you're waiting on a PA for a specific drug, these guides break down the exact documentation your prescriber needs:

Related Resources

Related Prescription & Insurance Guides

Editorial Policy: Refill Relay content is researched using publicly available PBM process documentation, CMS guidance, and standard industry prior authorization practices. Every article is reviewed for clarity, accuracy and usefulness before publication.

Evan Brown
About the Author
Evan Brown — Prescription Savings Researcher

Evan Brown is a prescription savings researcher who specializes in translating complex healthcare and pharmacy benefit processes — including PBM prior authorization workflows — into clear, actionable guidance for patients.

View Full Profile →
Dr. Megan Harris, MD
Medical Review
Dr. Megan Harris, MD — Board-Certified Internal Medicine

Dr. Megan Harris, MD reviews health content for accuracy, checking clinical documentation practices and prior authorization criteria against current CMS and industry guidance.

View Full Profile →

Contact Refill Relay